These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

319 related articles for article (PubMed ID: 25516667)

  • 41. Are colonoscopy and bowel ultrasound useful for assessing response to short-term therapy and predicting disease outcome of moderate-to-severe forms of ulcerative colitis?: a prospective study.
    Parente F; Molteni M; Marino B; Colli A; Ardizzone S; Greco S; Sampietro G; Foschi D; Gallus S
    Am J Gastroenterol; 2010 May; 105(5):1150-7. PubMed ID: 19997096
    [TBL] [Abstract][Full Text] [Related]  

  • 42. [Epidemiology and clinical characteristics of ulcerative colitis in north-eastern Mexico].
    Bosques-Padilla FJ; Sandoval-García ER; Martínez-Vázquez MA; Garza-González E; Maldonado-Garza HJ
    Rev Gastroenterol Mex; 2011; 76(1):34-8. PubMed ID: 21592901
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Ulcerative colitis in northern Portugal and Galicia in Spain.
    Barreiro-de Acosta M; Magro F; Carpio D; Lago P; Echarri A; Cotter J; Pereira S; Gonçalves R; Lorenzo A; Carvalho L; Castro J; Barros L; Dias JA; Rodrigues S; Portela F; Dias C; da Costa-Pereira A; ;
    Inflamm Bowel Dis; 2010 Jul; 16(7):1227-38. PubMed ID: 19924807
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Ulcerative colitis in China: retrospective analysis of 3100 hospitalized patients.
    Wang Y; Ouyang Q;
    J Gastroenterol Hepatol; 2007 Sep; 22(9):1450-5. PubMed ID: 17716349
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Decision tree for early introduction of rescue therapy in active ulcerative colitis treated with steroids.
    Mañosa M; Cabré E; Garcia-Planella E; Bernal I; Gordillo J; Esteve M; Zabana Y; Gassull MA; Domènech E
    Inflamm Bowel Dis; 2011 Dec; 17(12):2497-502. PubMed ID: 21472824
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Maintenance treatment with azathioprine in ulcerative colitis: outcome and predictive factors after drug withdrawal.
    Cassinotti A; Actis GC; Duca P; Massari A; Colombo E; Gai E; Annese V; D'Albasio G; Manes G; Travis S; Porro GB; Ardizzone S
    Am J Gastroenterol; 2009 Nov; 104(11):2760-7. PubMed ID: 19623172
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Beverage Consumption and Ulcerative Colitis: A Case-Control Study from Saudi Arabia.
    Almofarreh A; Sheerah HA; Arafa A; Ahamed SS; Alzeer O; Al-Hunaishi W; Mhimed MM; Al-Hazmi A; Lim SH
    Int J Environ Res Public Health; 2022 Feb; 19(4):. PubMed ID: 35206479
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Performance of the Montreal classification for inflammatory bowel diseases.
    Spekhorst LM; Visschedijk MC; Alberts R; Festen EA; van der Wouden EJ; Dijkstra G; Weersma RK;
    World J Gastroenterol; 2014 Nov; 20(41):15374-81. PubMed ID: 25386087
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Clinical course during the first 10 years of ulcerative colitis: results from a population-based inception cohort (IBSEN Study).
    Solberg IC; Lygren I; Jahnsen J; Aadland E; Høie O; Cvancarova M; Bernklev T; Henriksen M; Sauar J; Vatn MH; Moum B;
    Scand J Gastroenterol; 2009; 44(4):431-40. PubMed ID: 19101844
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Inflammatory bowel disease. An epidemiological and genetic study.
    Monsén U
    Acta Chir Scand Suppl; 1990; 559():1-42. PubMed ID: 2092567
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Incidence, Paris classification, and follow-up in a nationwide incident cohort of pediatric patients with inflammatory bowel disease.
    Müller KE; Lakatos PL; Arató A; Kovács JB; Várkonyi Á; Szűcs D; Szakos E; Sólyom E; Kovács M; Polgár M; Nemes É; Guthy I; Tokodi I; Tóth G; Horváth Á; Tárnok A; Csoszánszki N; Balogh M; Vass N; Bódi P; Dezsőfi A; Gárdos L; Micskey E; Papp M; Cseh Á; Szabó D; Vörös P; Veres G;
    J Pediatr Gastroenterol Nutr; 2013 Nov; 57(5):576-82. PubMed ID: 23820399
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Long-term clinical outcomes and factors predictive of relapse after 5-aminosalicylate or sulfasalazine therapy in patients with mild-to-moderate ulcerative colitis.
    Lee HJ; Jung ES; Lee JH; Hong SP; Kim TI; Kim WH; Cheon JH
    Hepatogastroenterology; 2012; 59(117):1415-20. PubMed ID: 22683958
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relapse rates of ulcerative colitis in remission and factors related to relapse].
    Park BJ; Lee KJ; Hwang JC; Sin SJ; Chung JY; Cho SW
    Korean J Gastroenterol; 2008 Jul; 52(1):21-6. PubMed ID: 19077487
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk of colectomy in patients with ulcerative colitis under thiopurine treatment.
    Cañas-Ventura A; Márquez L; Ricart E; Domènech E; Gisbert JP; García-Sanchez V; Marín-Jiménez I; Rodriguez-Moranta F; Gomollón F; Calvet X; Merino O; Garcia-Planella E; Vázquez-Romero N; Esteve M; Iborra M; Gutiérrez A; Vera M; Andreu M;
    J Crohns Colitis; 2014 Oct; 8(10):1287-93. PubMed ID: 24726696
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Self-reported frequency and severity of disease flares, disease perception, and flare treatments in patients with ulcerative colitis: results of a national internet-based survey.
    Bolge SC; Waters H; Piech CT
    Clin Ther; 2010 Feb; 32(2):238-45. PubMed ID: 20206781
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Do patients with ulcerative colitis diagnosed at a young age have more severe disease activity than patients diagnosed when older?
    Lee JH; Cheon JH; Moon CM; Park JJ; Hong SP; Kim TI; Kim WH
    Digestion; 2010; 81(4):237-43. PubMed ID: 20110709
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Plasma viscosity: a potential predictor of both medical treatment response and clinical stage of ulcerative colitis.
    Yakar T; Cosar AM; Gokturk HS; Kanat UG; Parlakgumus A; Kozanoglu I; Serin E
    Ann Ital Chir; 2016; 87():531-543. PubMed ID: 28070034
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.
    Herrinton LJ; Liu L; Fireman B; Lewis JD; Allison JE; Flowers N; Hutfless S; Velayos FS; Abramson O; Altschuler A; Perry GS
    Gastroenterology; 2009 Aug; 137(2):502-11. PubMed ID: 19445944
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Cutaneous manifestations in inflammatory bowel disease.
    Tromm A; May D; Almus E; Voigt E; Greving I; Schwegler U; Griga T
    Z Gastroenterol; 2001 Feb; 39(2):137-44. PubMed ID: 11253504
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Birth outcome in women with ulcerative colitis and Crohn's disease, and pharmacoepidemiological aspects of anti-inflammatory drug therapy.
    Nørgård BM
    Dan Med Bull; 2011 Dec; 58(12):B4360. PubMed ID: 22142578
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.